Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma

European Journal of Medical Research

C Gratzke³  CG Stief³  A Bachmann²  M Staehler³  O Reich³  F Bayrle³  D Tilki³  R Ganzer¹  MJ Bader³  M Seitz³  B Schlenker³ 

[1] Department of Urology, Krankenhaus St. Josef, University of Regensburg, Germany;Department of Urology, Basel University Hospital, Switzerland;Department of Urology, University Hospital Grosshadern, Ludwig-Maximilians- University Munich, Germany

关键词: nephron-sparing surgery;    open radical nephrectomy;    oncological follow-up;    renal cell carcinoma;   

Others  :  1093110
DOI  :  10.1186/2047-783X-15-6-253

 received in 2009-10-25, accepted in 2009-11-10,  发布年份 2010

【 摘 要 】

Objectives and Aims

To compare guideline recommendations with daily practice patterns in a German patient cohort with renal cell carcinoma.

Patients and methods

81 patients with T1 oder T2 renal cell carcinoma (RCC) were included in this prospective single-center study. All patients were operated in a single institution either by open radical nephrectomy (ORN) or nephron sparing surgery (NSS). Patients and doctors were evaluated using a written questionnaire with a follow-up of 12 months. Follow-up intervals, follow-up modalities (e. g. imaging modalities, laboratory controls of blood and urine) and the call on psycho-oncological support were evaluated.

Results

The majority of patients (72%) were followed up by their urologists. Follow-up examinations included abdominal ultrasound, urine and blood diagnostics, conventional chest x-rays, computed tomography (CT) of abdomen, chest or head or abdominal Magnetic Resonance Imaging (MRI). There were no significant differences between patients operated by ORN or NSS. In total, 12.5% of patients were asking for psycho-oncological support.

Conclusions

In general, patients were followed up according to existing guideline recommendations. Only a small proportion of patients asked for psycho-oncological treatment.

【 授权许可】

   
2010 I. Holzapfel Publishers

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Lindblad P: Epidemiology of renal cell carcinoma. Scand J Surg 2004, 93:88-96.
• [2]Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH: Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 2002, 11:171-8.
• [3]Lipworth L, Tarone RE, McLaughlin JK: The epidemiology of renal cell carcinoma. J Urol 2006, 176:2353-8.
• [4]Hock LM, Lynch J, Balaji KC: Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 2002, 167:57-60.
• [5]Luciani LG, Cestari R, Tallarigo C: Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology 2000, 56:58-62.
• [6]Patard JJ, Rodriguez A, Rioux-Leclercq N, Guille F, Lobel B: Prognostic significance of the mode of detection in renal tumours. BJU Int 2002, 90:358-63.
• [7]Ljungberg B, Hanbury DC, Kuczyk MA, et al.: Renal cell carcinoma guideline. Eur Urol 2007, 51:1502-10.
• [8]Gratzke C, Seitz M, Bayrle F, et al.: Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma. BJU Int 2009, 104:470-5.
• [9]Robson CJ: Radical nephrectomy for renal cell carcinoma. J Urol 1963, 89:37-42.
• [10]Staehler M, Haseke N, Stadler T, et al.: Renal surgery in the elderly: morbidity in patients aged > 75 years in a contemporary series. BJU Int 2008, 102:684-7.
• [11]Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML: Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol 2005, 173:391-4.
• [12]Itano NB, Blute ML, Spotts B, Zincke H: Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000, 164:322-5.
• [13]Sandhu SS, Symes A, A'Hern R, et al.: Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma. BJU Int 2005, 95:522-5.
• [14]Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P: A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001, 166:63-7.
• [15]Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS: Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 2005, 174:466-72. discussion 72; quiz 801
• [16]Leibovich BC, Blute ML, Cheville JC, et al.: Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003, 97:1663-71.
• [17]Ljungberg B, Alamdari FI, Rasmuson T, Roos G: Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 1999, 84:405-11.
• [18]Zisman A, Pantuck AJ, Wieder J, et al.: Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002, 20:4559-66.
• [19]Hafez KS, Novick AC, Campbell SC: Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 1997, 157:2067-70.
• [20]Johnsen JA, Hellsten S: Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 1997, 157:450-3.
• [21]Levy DA, Slaton JW, Swanson DA, Dinney CP: Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998, 159:1163-7.
• [22]Schrodter S, Hakenberg OW, Manseck A, Leike S, Wirth MP: Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma. J Urol 2002, 167:1630-3.
• [23]Patard JJ, Shvarts O, Lam JS, et al.: Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004, 171:2181-5. quiz 435
• [24]Ebert T, Fischer C: [When is aftercare useful in renal cell cancer?]. Urologe A 2005, 44:1018. 20-23
• [25]Goerling U, Odebrecht S, Schiller G, Schlag PM: [Need for psychosocial care in in-patients with tumour disease. Investigations conducted in a clinic specializing in tumour surgery]. Chirurg 2006, 77:41-6. discussion 6